Abstract
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Coronaviruses
Title:Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread
Volume: 2 Issue: 1
Author(s): Keith Lau*
Affiliation:
- iBonus Limited Unit 338, Building 16W Hong Kong Science Park, Shatin 8N.T.,Hong Kong
Keywords: COVID, asymptomatic, spread, corona, growth, asymptomatic growth.
Abstract:
Background: Coronavirus, called as, “the worst public health crisis for a generation,” is a malevolent silent killer.
Objective: One of the main concerns is containing the disease and avoiding the second wave of the pandemic, likely to arise because of the symptomatic patients, while ensuring the safe execution of day to day tasks.
Methods: The indirect transmission of coronavirus from asymptomatic individuals during incubation time and the identification of the people who have accidentally and unknowingly come in contact with infected but asymptomatic patients pose a significant challenge to the health care providers.
Results: Herein, for the first time, we have introduced a quantitative index; asymptomatic growth, to indicate whether the COVID-19 community spread is under control and if economic activities can be resumed.
Conclusion: More importantly, our system provides a feasible mechanism for improving the index to a level <1, a safety level at which normal economic activities can be conducted.
Export Options
About this article
Cite this article as:
Lau Keith *, Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200821160307
DOI https://dx.doi.org/10.2174/2666796701999200821160307 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry Understanding the Role of HDL during COVID-19 Infection
Coronaviruses SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments
Infectious Disorders - Drug Targets SARS-CoV-2: The Path of Prevention and Control
Infectious Disorders - Drug Targets Photocatalytic Inactivation of Bioaerosols: A Short Review on Emerging Technologies
Current Analytical Chemistry Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic
Coronaviruses Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options
Coronaviruses Neurovirulence of SARS CoV2: From Clinical Data to Preclinical Neuropsychological Exploration
Coronaviruses Computational Methods for Remote Homolog Identification
Current Protein & Peptide Science Self-Protection of Medical Workers in Traditional Hospitals and Clinics Against SARS-CoV-2 Infection
Coronaviruses Discovery of Potent Anti-SARS-CoV MPro Inhibitors
Current Computer-Aided Drug Design BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check
Current Pharmaceutical Biotechnology Interaction Between Two Residues in the Inter-Domain Interface of Escherichia coli Peptidase N Modulates Catalytic Activity
Protein & Peptide Letters Lead Molecule Prediction and Characterization for Designing MERS-CoV 3C-like Protease Inhibitors: An In silico Approach
Current Computer-Aided Drug Design Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review
Current Gene Therapy Prothymosin α and its C-Terminal Immunoreactive Decapeptide Show No Evidence of Acute Toxicity: A Preliminary <i>In Silico</i>, <i>In Vitro</i> and <i>In Vivo</i> Investigation
Current Medicinal Chemistry Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein
Infectious Disorders - Drug Targets A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies
Current Molecular Pharmacology Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses